Literature DB >> 28663095

Meta-analysis of stem cell transplantation for reflex hypersensitivity after spinal cord injury.

Xuemei Chen1, Bohan Xue2, Yuping Li2, Chunhua Song3, Peijun Jia2, Xiuhua Ren2, Weidong Zang4, Jian Wang5.   

Abstract

Stem cells have been used in novel therapeutic strategies for spinal cord injury (SCI), but the effect of stem cell transplantation on neuropathic pain after SCI is unclear. The current meta-analysis evaluates the effects of stem cell transplantation on neuropathic pain after SCI. We first conducted online searches of PubMed, Web of Science, China Academic Journals Full-text Database, and Wanfang Data for randomized controlled trials that compared stem cell transplantation and vehicle treatments in rodent models of neuropathic pain after SCI. Quality assessment was performed using Cochrane Reviewer's Handbook 5.1.0, and meta-analysis was conducted with RevMan 5.3. Then, we developed a rat model of SCI and transplanted bone marrow mesenchymal stem cells to verify meta-analysis results. Twelve randomized, controlled trials (n=354 total animals) were included in our meta-analysis and divided by subgroups, including species, timing of behavioral measurements, and transplantation time after SCI. Subgroup analysis of these 12 studies indicated that stem cell-treated animals had a higher mechanical reflex threshold than vehicle groups, with a significant difference in both rats and mice. The thermal withdrawal latency showed the same results in mouse subgroups, but not in rat subgroups. In addition, mesenchymal stem cell transplantation was an effective treatment for mechanical, but not thermal reflex hypersensitivity relief in rats. Transplantation showed a positive effect when carried out at 3 or 7days post-SCI. Stem cell transplantation alleviates mechanical reflex hypersensitivity in rats and mice and thermal reflex hypersensitivity in mice after SCI.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  meta-analysis; neuropathic pain; spinal cord injury; stem cells

Mesh:

Year:  2017        PMID: 28663095      PMCID: PMC5636655          DOI: 10.1016/j.neuroscience.2017.06.027

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  39 in total

1.  Cerebroprotection of flavanol (-)-epicatechin after traumatic brain injury via Nrf2-dependent and -independent pathways.

Authors:  Tian Cheng; Wenzhu Wang; Qian Li; Xiaoning Han; Jing Xing; Cunfang Qi; Xi Lan; Jieru Wan; Alexa Potts; Fangxia Guan; Jian Wang
Journal:  Free Radic Biol Med       Date:  2015-12-25       Impact factor: 7.376

2.  Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury.

Authors:  Jeff Biernaskie; Joseph S Sparling; Jie Liu; Casey P Shannon; Jason R Plemel; Yuanyun Xie; Freda D Miller; Wolfram Tetzlaff
Journal:  J Neurosci       Date:  2007-09-05       Impact factor: 6.167

3.  Risk factors for shoulder pain in patients with spinal cord injury: a multicenter study.

Authors:  G Ferrero; E Mijno; M V Actis; A Zampa; N Ratto; A Arpaia; A Massè
Journal:  Musculoskelet Surg       Date:  2015-05-23

4.  Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord.

Authors:  Soheila Karimi-Abdolrezaee; Eftekhar Eftekharpour; Jian Wang; Desiree Schut; Michael G Fehlings
Journal:  J Neurosci       Date:  2010-02-03       Impact factor: 6.167

5.  Pain following spinal cord injury: the impact on community reintegration.

Authors:  C Donnelly; J J Eng
Journal:  Spinal Cord       Date:  2005-05       Impact factor: 2.772

6.  Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats.

Authors:  Kyung Hee Lee; Haeyoung Suh-Kim; Ji Soo Choi; Sin-Soo Jeun; Eun Jin Kim; Sung-Soo Kim; Do Heum Yoon; Bae Hwan Lee
Journal:  Acta Neurobiol Exp (Wars)       Date:  2007       Impact factor: 1.579

7.  Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury.

Authors:  Jeannette E Davies; Christoph Pröschel; Ningzhe Zhang; Mark Noble; Margot Mayer-Pröschel; Stephen J A Davies
Journal:  J Biol       Date:  2008-09-19

8.  Treatment of rat spinal cord injury with a Rho-kinase inhibitor and bone marrow stromal cell transplantation.

Authors:  Takeo Furuya; Masayuki Hashimoto; Masao Koda; Akihiko Okawa; Atsushi Murata; Kazuhisa Takahashi; Toshihide Yamashita; Masashi Yamazaki
Journal:  Brain Res       Date:  2009-08-03       Impact factor: 3.252

9.  A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury.

Authors:  Philip J Siddall; Joan M McClelland; Susan B Rutkowski; Michael J Cousins
Journal:  Pain       Date:  2003-06       Impact factor: 6.961

10.  Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat.

Authors:  Takashi Amemori; Nataliya Romanyuk; Pavla Jendelova; Vit Herynek; Karolina Turnovcova; Pavel Prochazka; Miroslava Kapcalova; Graham Cocks; Jack Price; Eva Sykova
Journal:  Stem Cell Res Ther       Date:  2013-06-07       Impact factor: 6.832

View more
  2 in total

1.  The Effect of GABAergic Cells Transplantation on Allodynia and Hyperalgesia in Neuropathic Animals: A Systematic Review With Meta-Analysis.

Authors:  Zhen-Rong Zhang; Yao Wu; Wen-Jing Wang; Fang-Yong Wang
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

Review 2.  Is cell transplantation a reliable therapeutic strategy for spinal cord injury in clinical practice? A systematic review and meta-analysis from 22 clinical controlled trials.

Authors:  He Zhao; Qing-Ling Sun; Li-Jun Duan; Yong-Dong Yang; Yu-Shan Gao; Ding-Yan Zhao; Yang Xiong; He-Jun Wang; Jia-Wei Song; Kai-Tan Yang; Xiu-Mei Wang; Xing Yu
Journal:  Eur Spine J       Date:  2019-01-21       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.